Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067444 · ClinicalTrials.gov registry record · Phase 3
Depression Study In Elderly Patients
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 560
- Enrollment target
NCT00067444 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 560 participants.
The verdict
NCT00067444, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 560 participants
- Enrollment target
Study Summary
Major Depressive Disorder (MDD) Study in Elderly Outpatients
Interventions
- DRUG Paroxetine CR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 560 participants |
| Start Date | 2003-06 |
| Est. Completion | 2005-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00067444
The ClinicalTrials.gov registry entry for NCT00067444 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 560 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Paroxetine CR is the first listed.
NCT00067444 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00067444 about?
NCT00067444 is a clinical study titled "Depression Study In Elderly Patients". Major Depressive Disorder (MDD) Study in Elderly Outpatients
What is the current status of trial NCT00067444?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 560 participants. The study started on 2003-06. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00067444?
The interventions under investigation include: Paroxetine CR (DRUG).
Who is sponsoring clinical trial NCT00067444?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.